1311195-85-3

Basic information

• Product Name: (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone
• Synonyms: (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone
• CAS NO: 1311195-85-3
• Molecular Weight: 370.429
• Mol File: 1311195-85-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone(1311195-85-3)
• EPA Substance Registry System: (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone(1311195-85-3)

Safety Data

• Hazardous Substances Data: 1311195-85-3(Hazardous Substances Data)

Upstream product

• 103-85-5 monophenylthiourea 
• 2675-79-8 1-bromo-3,4,5-trimethoxybenzene 
• 1311196-06-1 N-methoxy-N-methyl-2-(phenylamino)thiazole-4-carboxamide 
• 126533-76-4 ethyl 2-(N-phenylamino)thiazole-4-carboxylate 
• 165683-01-2 2-(phenylamino)-1,3-thiazole-4-carboxylic acid 

Downstream Products

• 1311195-91-1 (2-(phenylamino)thiazol-4-yl)(3,4,5-trimethoxyphenyl)methanone hydrochloride 

Relevant articles and documents

Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl- thiazoles analogues as potent and orally bioavailable anticancer agents

In a continued effort to improve upon the previously published 4-substituted methoxybenzoyl-aryl-thiazole (SMART) template, we explored chemodiverse "B" rings and "B" to "C" ring linkage. Further, to overcome the poor aqueous solubility of this series of agents, we introduced polar and ionizable hydrophilic groups to obtain water-soluble compounds. For instance, based on in vivo pharmacokinetic (PK) studies, an orally bioavailable phenyl-amino-thiazole (PAT) template was designed and synthesized in which an amino linkage was inserted between "A" and "B" rings of compound 1. The PAT template maintained nanomolar (nM) range potency against cancer cell lines via inhibiting tubulin polymerization and was not susceptible to P-glycoprotein mediated multidrug resistance in vitro, and markedly improved solubility and bioavailability compared with the SMART template (45a-c (PAT) vs 1 (SMART)).